2m 2m 2m 2m 2m 2m 2m
Vertex Pharma (VRTX)
NASDAQ
$532.28-$2.89 (-0.54%)
Price as of Oct 22, 2026 7:59 PM EDT- $132.9BMarket Cap
- 23.00%1-Year Change
- BiotechnologyIndustry
Vertex Pharma (VRTX)
$532.28-$2.89 (-0.54%)
VRTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $535.17 | ||
Change | +$9.87 (+1.92%) | ||
Open | $527.18 | ||
High | $537.81 | ||
Low | $521.29 | ||
Previous Close | $524.52 | ||
Volume | 1,641,609 | ||
30-Day Average Volume | 1,189,365 | ||
1-Week Change | 5.22% | ||
1-Month Change | 2.70% | ||
1-Year Change | 23.00% | ||
3-Year Change | 44.95% | ||
5-Year Change | 180.36% | ||
Fundamentals | |||
Shares Outstanding | 253.5M | ||
Total Assets | $27.4B | ||
Market Cap | $132.9B | ||
Enterprise Value | $126.8B | ||
Period: QTR TTM FY | |||
Revenue | $3.3B | ||
Net Income | $1.1B | ||
Free Cash Flow | $1.0B | ||
EBIT | $1.4B | ||
EBITDA | $1.4B | ||
Net Working Capital | $8.6B | ||
EPS | $4.31 | ||
Enterprise Value/EBITDA | 88 | ||
Enterprise Value/Revenue | 38 | ||
P/B | 7 | ||
P/E | 122 | ||
PEG | 17 | ||
Price/Free Cash Flow | 131 | ||
Price/Operating Cash Flow | 118 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue